Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults

Clinical trial NCT05605470 · COMPLETED

Trial details

NCT number: NCT05605470
Sponsor: Technovalia, Pty Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19, SARS CoV 2 Infection

Start date: 2023-01-19
Primary completion: 2024-07-15
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.